Agnès Gouble

2.0k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Agnès Gouble is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Agnès Gouble has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Oncology and 8 papers in Genetics. Recurrent topics in Agnès Gouble's work include CRISPR and Genetic Engineering (22 papers), CAR-T cell therapy research (22 papers) and RNA Interference and Gene Delivery (8 papers). Agnès Gouble is often cited by papers focused on CRISPR and Genetic Engineering (22 papers), CAR-T cell therapy research (22 papers) and RNA Interference and Gene Delivery (8 papers). Agnès Gouble collaborates with scholars based in France, United States and United Kingdom. Agnès Gouble's co-authors include Julianne Smith, Andrew M. Scharenberg, Román Galetto, Aymeric Duclert, Philippe Duchâteau, Sylvain Arnould, Céline Lebuhotel, Laurent Poirot, Frédéric Pâques and Martin Pulé and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Agnès Gouble

34 papers receiving 1.2k citations

Hit Papers

Multiplex Genome-Edited T-cell Manufacturing Platform for... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnès Gouble France 16 904 635 456 175 160 37 1.3k
Bian Hu China 17 1.1k 1.3× 389 0.6× 360 0.8× 81 0.5× 196 1.2× 30 1.5k
Fabienne Cocchiarella Italy 15 977 1.1× 545 0.9× 386 0.8× 105 0.6× 329 2.1× 17 1.6k
Timothy Davis United States 12 768 0.8× 367 0.6× 320 0.7× 44 0.3× 146 0.9× 17 1.1k
Ulrike Mock Germany 11 526 0.6× 463 0.7× 271 0.6× 134 0.8× 216 1.4× 20 852
Ashlesha Odak United States 4 775 0.9× 1.1k 1.7× 469 1.0× 328 1.9× 353 2.2× 5 1.3k
Alexander Astrakhan United States 12 466 0.5× 302 0.5× 327 0.7× 69 0.4× 187 1.2× 18 759
Hiroki Torikai United States 17 577 0.6× 957 1.5× 452 1.0× 235 1.3× 634 4.0× 32 1.4k
Walker S. Lahr United States 11 731 0.8× 416 0.7× 269 0.6× 80 0.5× 221 1.4× 21 1.0k
Andrea Calabria Italy 17 1.1k 1.2× 400 0.6× 736 1.6× 44 0.3× 233 1.5× 35 1.6k
Lupeng Ye China 17 966 1.1× 509 0.8× 227 0.5× 77 0.4× 362 2.3× 35 1.4k

Countries citing papers authored by Agnès Gouble

Since Specialization
Citations

This map shows the geographic impact of Agnès Gouble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Gouble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Gouble more than expected).

Fields of papers citing papers by Agnès Gouble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Gouble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Gouble. The network helps show where Agnès Gouble may publish in the future.

Co-authorship network of co-authors of Agnès Gouble

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Gouble. A scholar is included among the top collaborators of Agnès Gouble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Gouble. Agnès Gouble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aranda-Orgillés, Beatriz, Isabelle Chion-Sotinel, Jorge Postigo, et al.. (2023). Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies. Cancer Immunology Research. 11(7). 946–961. 7 indexed citations
2.
Sugita, Mayumi, Román Galetto, Hongliang Zong, et al.. (2022). Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia. Nature Communications. 13(1). 2227–2227. 46 indexed citations
4.
Quintana-Bustamante, Óscar, Israel Orman, Raúl Torres, et al.. (2019). Gene editing of PKLR gene in human hematopoietic progenitors through 5’ and 3’ UTR modified TALEN mRNA. PLoS ONE. 14(10). e0223775–e0223775. 22 indexed citations
5.
Guzmán, Mónica L., Mayumi Sugita, Hongliang Zong, et al.. (2016). Allogeneic Tcrα/β Deficient CAR T-Cells Targeting CD123 Prolong Overall Survival of AML Patient-Derived Xenografts. Blood. 128(22). 765–765. 13 indexed citations
6.
Galetto, Román, Céline Lebuhotel, Agnès Gouble, et al.. (2016). 397. Allogenic CAR T-Cells Targeting CD123 Effectively Eliminate Myeloid Leukemia Cells. Molecular Therapy. 24. S157–S158. 1 indexed citations
7.
Poirot, Laurent, Brian Philip, Cécile Schiffer-Mannioui, et al.. (2015). Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies. Cancer Research. 75(18). 3853–3864. 468 indexed citations breakdown →
9.
Galetto, Román, Céline Lebuhotel, Agnès Gouble, et al.. (2015). TCRab Deficient CAR T-Cells Targeting CD123: An Allogeneic Approach of Adoptive Immunotherapy for the Treatment of Acute Myeloid Leukemia (AML). Blood. 126(23). 2555–2555. 2 indexed citations
10.
Smith, Julianne, Laurent Poirot, Brian Philip, et al.. (2015). UCART19, an allogeneic “off-the-shelf” adoptive T-cell immunotherapy against CD19+ B-cell leukemias.. Journal of Clinical Oncology. 33(15_suppl). 3069–3069. 1 indexed citations
11.
Galetto, Román, Céline Lebuhotel, Agnès Gouble, Cécile Schiffer-Mannioui, & Julianne Smith. (2014). Allogenic T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML). Blood. 124(21). 1116–1116. 1 indexed citations
12.
Rivière, Julie, Julia Hauer, Laurent Poirot, et al.. (2014). Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells. Gene Therapy. 21(5). 529–532. 12 indexed citations
13.
He, C, Agnès Gouble, Laurent Poirot, et al.. (2014). Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity. Gene Therapy. 21(8). 759–766. 9 indexed citations
14.
Galetto, Román, Céline Lebuhotel, Laurent Poirot, et al.. (2014). Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cells. Molecular Therapy — Methods & Clinical Development. 1. 14021–14021. 8 indexed citations
15.
Popplewell, Linda, Taeyoung Koo, X. Leclerc, et al.. (2013). Gene Correction of a Duchenne Muscular Dystrophy Mutation by Meganuclease-Enhanced Exon Knock-In. Human Gene Therapy. 24(7). 692–701. 50 indexed citations
16.
Certo, Michael T., Kamila Gwiazda, Blythe Sather, et al.. (2012). Coupling endonucleases with DNA end–processing enzymes to drive gene disruption. Nature Methods. 9(10). 973–975. 73 indexed citations
17.
Arnould, Sylvain, Christophe Perez, Jean‐Pierre Cabaniols, et al.. (2007). Engineered I-CreI Derivatives Cleaving Sequences from the Human XPC Gene can Induce Highly Efficient Gene Correction in Mammalian Cells. Journal of Molecular Biology. 371(1). 49–65. 107 indexed citations
18.
Gouble, Agnès, Julianne Smith, S. Bruneau, et al.. (2006). Efficient in toto targeted recombination in mouse liver by meganuclease‐induced double‐strand break. The Journal of Gene Medicine. 8(5). 616–622. 34 indexed citations
19.
Levadoux‐Martin, Marilyne, et al.. (2003). Impaired gametogenesis in mice that overexpress the RNA‐binding protein HuR. EMBO Reports. 4(4). 394–399. 18 indexed citations
20.
Gouble, Agnès & Dominique Morello. (2000). Synchronous and regulated expression of two AU-binding proteins, AUF1 and HuR, throughout murine development. Oncogene. 19(47). 5377–5384. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026